HPLC Analysis of TXB2 Content in Platelet and the Anti-platelet Actions of Acathopanax Senticosus

Abstract

Abstract: TXB₂ content in platelet were analysed by high-performance liquid chromatography (HPLC) using a pre-column derivatization method,in which a fluorescentreagent,4-bro-momethyl-7-methoxycoumarin (BrMmc) was used.The mothod was applied to studing the effects of Acanthopanax Senticosus (A.S.) extract,a Chinese medicine,on platelet func-tion.The platelet TXB₂ were extracted by a Sep-Pak C₁₈ (waters).In the presence of 18-crown-6 and K₂CO₃,BrMmc reacted with carboxylic group(—COOH) of TXB₂ to form a fluorescent ester (BrMmc-TXB₂),which was seperated on a column (250mm×4.6mm I.D.)packed with Zorbax-ODS (6 μm,Dupont Instruments)and monitored by a fluorescent detector in Ex 345 nm and Em 405 nm.The mobile phase (acetonitrile:water:phosphoric acid;60:40:0.1 V/V),flowed at 1 ml/min at 30℃.The seperation of BrMmc-TXB₂ was completed in 20min.The detection limit was 15 ng using the external standard method.The anti-platelet actions of A.S.in rabbit were studied.The resultes (in vitro) showed that the platelet aggregations induced by AA and ADP were potently inhibited by A.S.in a dose-de-pendent manner and the AA-induced TXB₂ formation in platelet was also reduced.After in-travenous injection of A.S.(120mg/kg),the platelet aggregations induced by AA and ADP were inhibited and the effects lasted 30 and 45 min,respectively.

Key words: RP-HPLC, TXB₂, platelet

Yang Qiushen;Jin Youyu;Wang Jinsheng. HPLC Analysis of TXB₂ Content in Platelet and the Anti-platelet Actions of Acathopanax Senticosus[J]. Journal of Capital Medical University, 1991, 12(3): 171-179.

[1]	Zi Xiaohui, Xia Xue, Li jing, Zhang Xiaoli, Zhou Quan, Wang Anxin, Wang Yilong. Advances in the application of antiplatelet therapy in intravenous thrombolysis for acute ischemic stroke patients [J]. Journal of Capital Medical University, 2025, 46(2): 234-242.
[2]	Wang Yinping, Meng Cancan, Wu Wenjuan, Yang Zhitang. The expressions of CD62P, CD40L, and Rev-erbα after ischemic stroke on different onset times [J]. Journal of Capital Medical University, 2025, 46(1): 34-40.
[3]	Zhang Meng, Ma Yongxin, Jia Qiong , Zhang Dongwei, Zhang Xinhong, Xu Yaoming . Clinical observation on the efficacy and safety of intravenous thrombolysis in the treatment of acute mild non-disabling ischemic stroke: a single-center retrospective observational study [J]. Journal of Capital Medical University, 2025, 46(1): 56-62.
[4]	Huang Xiaohui, Wang Xinwei, Wu Jie. Predictive value of neutrophil to lymphocyte ratio and platelet count combined with D-dimer in the prognosis of children with severe pneumonia complicated with sepsis [J]. Journal of Capital Medical University, 2024, 45(4): 721-726.
[5]	Yao Yi, Tang Xiaofang, Song Ying, Jiang Lin, Qiao Shubin, Yuan Jinqing. Analysis on influencing factors of antiplatelet drug resistance in patients with acute coronary syndrome [J]. Journal of Capital Medical University, 2021, 42(5): 799-803.
[6]	Liu Jing, Wu Shunxiang, Han Yanfu, Xu Guang, Cui lei. Clinical observation of autologous platelet rich fibrin in the treatment of refractory wounds [J]. Journal of Capital Medical University, 2020, 41(6): 876-881.
[7]	Wang Zhenzhong, Yu Fei, Yang Bo, Ma Lifeng. Inhibition effect of platelet-rich plasma on matrix metalloproteinase-13 expression in rabbit osteoarthritis cartilage [J]. Journal of Capital Medical University, 2020, 41(6): 923-928.
[8]	Li Xing, Lu Zijin, Wang Xiaodong, Wang Wei. Anti-platelet strategies in patients with percutaneous coronary intervention based on CYP2C19 gene polymorphism and platelet function [J]. Journal of Capital Medical University, 2020, 41(6): 960-964.
[9]	Peng Rongrong, Liu Yunnan, Yang Xiaoli, Yang Dongyan. Study on clinical demand prediction model of apheresis platelets based on time series analysis [J]. Journal of Capital Medical University, 2020, 41(2): 231-236.
[10]	Xia Pengfei, Wang Wei, Zou Liang, Ma Yingming. Efficacy and safety of modified antiplatelet preparation in patients with high on-treatment platelet reactivity after endovascular coiling for unruptured intracranial aneurysms [J]. Journal of Capital Medical University, 2018, 39(1): 143-147.
[11]	Pu Changsheng, Zheng Zhi, Cai Jun, Tang Huazhen, Zhang Jun, Zhang Zhongtao. Expression and interaction of PDZK1 and PDGFR-β in adenocarcinoma of the esophagogastric junction of Siewert Ⅱ [J]. Journal of Capital Medical University, 2017, 38(6): 804-809.
[12]	Liu Meng, Dou Yunpeng, Gu Li, Lyu Zhe, Wang Yimin, Liu Yingmei, An Yunqing, Cao Bin. Studies of serum biomarkers to differentiate and diagnose acute pneumonia pathogens infection [J]. Journal of Capital Medical University, 2016, 37(5): 636-640.
[13]	Xiang Tianqing, LyuYalin, Yu Lan, Duan Xiangqing, Ding Fang, Cai Qian. Clinical observation of the hemorrhagic risk in patients with low-dose aspirin therapy following dental implantation [J]. Journal of Capital Medical University, 2016, 37(3): 270-274.
[14]	Fu Lu, Wang Zhaohui. Role of CD62p in the diagnosis of acute brain infarction disease [J]. Journal of Capital Medical University, 2015, 36(5): 714-717.
[15]	Cui Wei, Liu Sa, Dong Lei, Yuan Hui, Yang Ping, Wu Yina, Li Yulin. Flow cytometry for assessing circulating platelet activation and platelet-leukocyte adhesion [J]. Journal of Capital Medical University, 2015, 36(3): 414-419.

HPLC Analysis of TXB₂ Content in Platelet and the Anti-platelet Actions of Acathopanax Senticosus

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments